This guide is educational information, not personal medical advice. The source-check date records editorial work, not a clinician review. Read our medical disclaimer.
Why testing continues after the initial visit
The initial test helps establish HIV status at the time of the visit, but it cannot rule out infection from the exposure that just occurred. PEP medicines may suppress HIV and delay detection if infection occurs, so even a negative result soon after the course is not necessarily the final answer.
Use the date PEP started as the anchor for follow-up. Tell the care team about missed doses, an incomplete course, or another possible exposure; each can affect interpretation and the follow-up plan. Keep appointments even if you feel well.
Sources for this section: [2]
The interim and final tests
CDC’s 2025 nonoccupational PEP guidance describes an interim laboratory antigen/antibody test together with a diagnostic nucleic acid test at four to six weeks after PEP initiation. A negative interim result does not by itself rule out infection. The clinician may defer this interim test for someone who started PEP within 24 hours of exposure, completed it without missed doses, and is not considering PrEP.
CDC recommends final testing intended to rule out HIV at 12 weeks after PEP initiation, using both a laboratory antigen/antibody test and a diagnostic NAT. That is approximately eight weeks after completing a full 28-day PEP course. New exposures or a transition to PrEP can affect the individual plan.
Sources for this section: [2]
Arrange the blood draw and results
Before leaving the initial visit, ask where to have blood drawn, whether a laboratory order or appointment is needed, when to expect results, and who to call if they do not arrive. A home antibody test should not replace the agreed laboratory follow-up.
Contact the care team if you have symptoms, a reactive result, difficulty attending, or questions about missed medication. They can determine whether additional testing is needed and interpret results in the context of the medicines and exposure history.
Sources & editorial note
We use the sources below to support this guide. Follow a source link for its full guidance and any later changes. Source checking does not replace medical review or a conversation with your care team.
- Getting Tested for HIV CDC. Accessed .
- Antiretroviral Postexposure Prophylaxis: CDC Recommendations, 2025 CDC. Accessed .
Prepared by HIV Guide editorial team. How we write and check our guides · Contact and corrections information



